Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001636178-25-000006

CFO AND TREASURER sold 21,000 shares at an average $470.36 ($9,877,535)

  • CFO AND TREASURER acquired 21,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

EDGEMOND JAMES · CFO AND TREASURER

Table I: Non-derivative

14 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-17 Exercise or conversion : show line 1 in the form 10b5-1 +10,688 $146.03 $1,560,769 18,806 D
2025-11-17 Sale : show line 2 in the form 10b5-1 −3,591 $470.34 $1,688,978 15,215 D
2025-11-17 Sale : show line 3 in the form 10b5-1 −2,657 $471.22 $1,252,030 12,558 D
2025-11-17 Sale : show line 4 in the form 10b5-1 −1,999 $472.13 $943,786 10,559 D
2025-11-17 Sale : show line 5 in the form 10b5-1 −920 $473.68 $435,783 9,639 D
2025-11-17 Sale : show line 6 in the form 10b5-1 −639 $474.80 $303,397 9,000 D
2025-11-17 Sale : show line 7 in the form 10b5-1 −798 $475.89 $379,761 8,202 D
2025-11-17 Sale : show line 8 in the form 10b5-1 −84 $476.47 $40,024 8,118 D
Open-market sales · 21,000 sh · avg $470.36 · $9,877,535

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-11-17 Exercise or conversion : show line 15 in the form 10b5-1 Stock Option −10,312 $146.03 2027-03-15 10,312 0 D
2025-11-17 Exercise or conversion : show line 16 in the form 10b5-1 Stock Option −10,688 $146.03 2027-03-15 10,688 21,517 D
Loading xslF345X05/primarydocument.xml…